Human Monoclonal Antibody MBL‐HCV1 Delays HCV Viral Rebound Following Liver Transplantation: A Randomized Controlled Study

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-6143|13|4|1047-1054

ISSN： 1600-6135

Source： AMERICAN JOURNAL OF TRANSPLANTATION, Vol.13, Iss.4, 2013-04, pp. : 1047-1054

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized, placebo‐controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 8, 2015-08 ,pp. : 658-664

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of HCV prior to liver transplantation to prevent HCV recurrence – Wise or wasteful?

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 1, 2015-01 ,pp. : 9-11

John Wiley & Sons Inc

Access to resources Recommend Favorite

ABO-Incompatible Living Donor Liver Transplantation in Focus of Antibody Rebound

By  

Transfusion Medicine and Hemotherapy, Vol. 44, Iss. 1, 2016-11 ,pp. : 46-51

Karger

Access to resources Recommend Favorite

Curing hepatitis C virus (HCV) after organ transplantation: Increased risk of rejection following HCV elimination

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 20, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prophylaxis of HCV reinfection and direct‐acting antiviral agents during liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 10, 2015-10 ,pp. : 1327-1329

John Wiley & Sons Inc

Access to resources Recommend Favorite